Table 2.
Univariate analysis of OS and PFS in patients
| Variables | OS | PFS | ||
|---|---|---|---|---|
| HR(95% Cl) | P | HR(95% Cl) | P | |
| Sex (male vs. female) | 0.482(0.194-1.215) | 0.122 | 0.535(0.212-1.351) | 0.186 |
| Age (<=57 vs. >57) | 0.709(0.409-1.230) | 0.221 | 1.206(0.693-2.100) | 0.508 |
| TACE therapy (no vs. yes) | 1.514(0.463-4.949) | 0.492 | 0.786(0.244-2.533) | 0.686 |
| Radiotherapy (no vs. yes) | 0.703(0.398-1.242) | 0.225 | 0.723(0.401-1.304) | 0.281 |
| Surgery (no vs. yes) | 1.759(0.901-3.435) | 0.098 | 1.074(0.539-2.139) | 0.839 |
| DC-CTL therapy (no vs. yes) | 1.928(1.117-3.327) | 0.018 | 2.671(1.536-4.645) | 0.001 |
| T (2 vs. 3,4) | 0.505(0.226-1.127) | 0.095 | 0.811(0.363-1.812) | 0.610 |
| N (0 vs. 1,2) | 1.308(0.737-2.321) | 0.358 | 1.063(0.593-1.905) | 0.837 |
| TNM Stage (IIA vs. IIB, IIC, III, IV) | 0.578(0.229-1.460) | 0.246 | 1.007(0.397-2.555) | 0.988 |
Abbreviation: CI, confidence interval.